In the present study while whole blood exposure to hormone-therapy treated breast cancer cells decreased ESR1 expression substantively, corresponding changes in EMT-associated genes indicated higher levels of CDH1 and vimentin in T47D cells than MCF7 cells. The gene discussed is ESR1; the disease is breast carcinoma.